PROTEOMIC ANALYSIS OF CANCER PATIENT PLASMA SAMPLES
ID: 75F40125Q00169Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

Research and Development in the Social Sciences and Humanities (541720)

PSC

SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA (B529)

Original Source

https://sam.gov/opp/7b9573e6c4bf47ecb1dc9711fee3b204/view
Timeline
    Description

    The U.S. Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking a contractor to conduct a quantitative proteomic analysis of cancer patient plasma samples under solicitation number FDA-RFQ-75F40125Q00169. The objective is to analyze 100 human plasma samples for over 5000 proteins related to cardiotoxicity, cancer, and inflammation, with results delivered in organized parquet files within 60 days. This analysis is crucial for advancing research in cancer treatment and ensuring rigorous scientific evaluation of public health outcomes. Interested parties should contact Ronald Paraham at Ronald.Paraham@fda.hhs.gov for further details, with the contract being a firm-fixed price agreement and a performance period of 6 to 8 months.

    Point(s) of Contact
    Ronald Paraham
    Ronald.Paraham@fda.hhs.gov
    Files
    Title
    Posted
    FDA-RFQ-75F40125Q00169_LY.docx
    The U.S. Food and Drug Administration (FDA) issued a Request for Quote (RFQ) for quantitative proteomic analysis of cancer patient plasma samples under solicitation number FDA-RFQ-75F40125Q00169. This procurement aims to measure cardiotoxicity biomarkers using multiplex immunoassays, specifically targeting over 5000 proteins related to cardiovascular diseases, cancer, and inflammation. The contractor must deliver analysis results for 100 human plasma samples within 60 days, providing data in organized parquet files, and should ensure high sensitivity, specificity, and reproducibility of results with minimal sample volumes. Key requirements include using next-generation sequencing coupled with antibody-based assays, internal controls for data normalization, and the ability to assess bridging samples from prior analyses. The contract is a firm-fixed price agreement with a performance period of 6 to 8 months. The FDA retains ownership of all data produced. Invoices must be submitted electronically, and all work will occur at the contractor's facility, shipping results to the FDA’s National Center for Toxicological Research in Jefferson, AR. The RFQ is part of the FDA’s commitment to advancing research in cancer treatment, demonstrating a focus on rigorous scientific evaluation and public health outcomes.
    Lifecycle
    Title
    Type
    PROTEOMIC ANALYSIS OF CANCER PATIENT PLASMA SAMPLES
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    FDA BIMO Inspections and Compliance Support
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is conducting a Sources Sought notice to identify small businesses capable of providing professional services for its Bio-Research Monitoring (BIMO) program. The FDA aims to modernize and consolidate its IT systems to enhance inspections and compliance support, requiring expertise in areas such as workflow management, data integration, and the development of a centralized BIMO database and analytics platform. This initiative is critical for improving the efficiency and effectiveness of BIMO inspections across all centers, and interested parties must submit their responses by January 5, 2026, to Michelle Dacanay at michelle.dacanay@fda.hhs.gov.
    FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY26 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. This opportunity aims to acquire basic and applied research and development proposals that support regulatory science and innovation, focusing on modernizing the evaluation of FDA-regulated products, enhancing post-market surveillance, and improving public health preparedness. The FDA emphasizes the importance of advancing scientific knowledge in various research areas, including new methodologies and advanced manufacturing techniques, to ensure product safety and efficacy across diverse populations. Interested parties must submit a checklist, concept paper, and full proposal by February 24, 2026, with early submissions encouraged. For further inquiries, contact Ian Weiss at Ian.Weiss@fda.hhs.gov or call 301-796-5728.
    Single-Nuclei Multiome Analysis of Human Brain Tissue, iPSC-Derived Cells and Human Dorsal Root Ganglion
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified entities to conduct a Single-Nuclei Multiome Analysis of Human Brain Tissue, iPSC-Derived Cells, and Human Dorsal Root Ganglion. This procurement aims to advance research in medical laboratory testing by analyzing complex biological samples to enhance understanding of neurological conditions. The work is critical for developing innovative treatments and therapies in the field of neuroscience. Interested parties can reach out to Maggie Brant at maggie.brant@nih.gov or KJ Shaikh at KJ.Shaikh@nih.gov for further details regarding this opportunity.
    FlowJo - Flow Cytometry Analysis Software Justification
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure 180 site licenses for Flow Cytometry Analysis Software (FlowJo) to support research initiatives at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This software is critical for analyzing flow cytometry data, which is essential in various biomedical research applications. Interested vendors can reach out to Derek Bowks at derek.bowks@nih.gov or by phone at 301-594-7712 for further details regarding this procurement opportunity.
    Biospecimen Core Resource
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) under the National Cancer Institute (NCI), is seeking to establish a Biospecimen Core Resource (BCR) to support various biospecimen-related activities. The BCR will operate under documented Standard Operating Procedures (SOPs) to facilitate the collection, processing, distribution, and storage of biospecimens as outlined in NCI Task Orders. This initiative is crucial for advancing cancer research and ensuring the integrity and availability of biospecimens for scientific studies. Interested parties can reach out to Apisit Viriya at apisit.viriya@nih.gov or Mataya Robinson at mataya.robinson@nih.gov for further details regarding this opportunity.
    Irradiated Rodent Feed
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for the procurement of Certified and Irradiated Rodent Diet Feed NIH-07 and NTP-2000, along with Assay Analysis, under the combined synopsis/solicitation 76F40125Q132188. This opportunity is set aside for small businesses and requires adherence to specific technical standards regarding feed irradiation, contaminant analysis, nutritional content, and facility sanitation, as outlined in the solicitation documents. The goods are essential for research purposes at the National Center for Toxicological Research (NCTR) and will be procured through a Single Award Indefinite Delivery, Indefinite Quantity (ID/IQ) contract with a guaranteed minimum of $5,000 and an estimated maximum of $350,000 over a five-year ordering period. Proposals are due by December 22, 2025, at 1:00 PM Central Time, and interested parties can contact Howard Nesmith at howard.nesmith@fda.hhs.gov or by phone at 870-543-7459 for further information.
    FDA Data Dashboard Bridge Order
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is issuing a sole source bridge order to Salient CRGT, Inc. for the FDA Data Dashboard project. This procurement aims to support the FDA’s Division of Enforcement Systems Solutions through a limited source justification in accordance with FAR 8.405-6 requirements, utilizing the GSA MAS Schedule 54151S for Information Technology Professional Services. The services provided are critical for maintaining and enhancing the FDA's data management capabilities, ensuring effective enforcement and regulatory compliance. Interested parties can reach out to Michelle Dacanay at michelle.dacanay@fda.hhs.gov for further details regarding this opportunity.
    American National Standards Institute (ANSI) Standards Membership
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking to procure a Brand Name American National Standards Institute (ANSI) Standards Membership through a Request for Quotation (RFQ) identified as 75F40126Q00014. The objective of this acquisition is to secure unlimited FDA user access to ANSI standards for a base year and four option years, which is critical for the FDA's regulatory functions, particularly in the area of medical devices. This membership will enable the FDA to maintain access to essential medical device standards and participate in various standards development committees, ensuring compliance with regulatory responsibilities. Interested contractors must submit their fixed-price quotes to Brian Wodzisz via email by 3:00 PM ET on December 30, 2025, with quotes evaluated based on the lowest price technically acceptable criteria.
    NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), has issued a Special Notice regarding subcontracting opportunities at the Frederick National Laboratory for Cancer Research (FNLCR). This opportunity focuses on the need for laboratory assays and services to assess cytokines in nasal mucosa samples for up to nine phase 1 trials and two phase 2 trials related to the NextGen COVID-19 vaccine program, which is critical for advancing the National Institute of Allergy and Infectious Diseases (NIAID) mission. The FNLCR, operated by Leidos Biomedical Research, Inc., plays a vital role in cancer and AIDS research, and this notice aims to inform potential subcontractors of the requirements without constituting a formal solicitation. Interested parties can reach out to Tara Phillips at tara.phillips@nih.gov for further details regarding Solicitation/RFP No. S26-111, with a response date set for January 14, 2026.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to the diagnosis, prevention, or treatment of diseases. The procurement aims to establish contracts for domestic delivery of medical laboratory services, ensuring compliance with all relevant state, federal, and local regulations, including necessary licenses and permits for testing services. This opportunity is critical for enhancing patient care through accurate diagnostic testing, with the expectation that offerors will provide new items only, adhering to FDA regulatory requirements. Interested vendors can contact the FSS Help Desk at Fss.Help@va.gov or call 708-786-7737 for further details, as the solicitation is currently pending and specific deadlines for proposal submissions will be outlined in the official solicitation documents.